FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1000111000001101: Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22678301000001117 Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22678401000001113 Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has VMP Amitriptyline 25mg / Perphenazine 2mg tablets true Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has VMP Amitriptyline 25mg / Perphenazine 2mg tablets false Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Is pack of Product containing precisely amitriptyline 25 milligram and perphenazine 2 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has active ingredient Amitriptyline false Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has active ingredient Perphenazine false Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has VMP Product containing precisely amitriptyline 25 milligram and perphenazine 2 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has specific active ingredient Amitriptyline hydrochloride true Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has specific active ingredient Perphenazine true Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Triptafen tablets (Goldshield Healthcare Ltd) 100 tablet 10 x 10 tablets Is a True Amitriptyline 25mg / Perphenazine 2mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start